Tirzepatide (brand names Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that produces higher average weight loss, roughly 18 to 25% of body weight in clinical trials
CrossRef Urine biomarkers in type 2 diabetes mellitus with or without microvascular complications Chanyuan Zhang, Tiebing Liu, Xiaoqian Wang, Jing Yang, Dongfang Qin, Yin Liang, Xuejing Wang Nutrition & Diabetes.2024;[Epub] CrossRef Quercetin4ODglucopyranoside inhibits podocyte injury by SIRT5mediated desuccinylation of NEK7 Menghua Wu, Xiaoli Ye Clinical and Experimental Pharmacology and Physiology.2024;[Epub] CrossRef Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway Yinghui Wang, Donglin Lu, Shasha Lv, Xiangchun Liu, Gang Liu Renal Failure.2024;[Epub] CrossRef Real-World Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Mild-to-Moderate Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Retrospective, Single-Arm Clinical Trial Yongsheng Cao, Jianqin Zhao, Yanjuan Ma, Shujie Cao, Ying Liu Diabetes, Metabolic Syndrome and Obesity.2024
Consider timing : Taking L-Carnitine 30 to 60 minutes before training can maximize its potential to increase the use of fats as an energy source
Only the patients body weight was found to have an effect on semaglutide exposure
ALSO ON RAPPLER What are the PH Maritime Zones Act, Archipelagic Sea Lanes Act all about
